The University at Buffalo's Office of Science Technology Transfer and Economic Outreach (STOR) has announced that licensing and research agreements have been completed with Reichert, Inc., paving the way for developing and marketing a cell volume cytometer (CVC), whose applications include the detection of drug/cell interactions, bacterial sensitivity to antibiotics and cancer cell susceptibility to chemotherapeutic agents.